VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

Valtoco(®) is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older. Although IV and rectal diazepam are already used to treat seizure clusters, Valt...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neurol Int
Huvudupphovsmän: Cornett, Elyse M., Amarasinghe, Sam N., Angelette, Alexis, Abubakar, Tunde, Kaye, Adam M., Kaye, Alan David, Neuchat, Elisa E., Urits, Ivan, Viswanath, Omar
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2021
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931041/
https://ncbi.nlm.nih.gov/pubmed/33670456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/neurolint13010007
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk